class name | count |
---|---|
Liliopsida | 2 |
rosids | 1 |
asterids | 1 |
class name | count |
---|---|
Araceae | 1 |
Brassicaceae | 1 |
Enterobacteriaceae | 1 |
Iridaceae | 1 |
Asteraceae | 1 |
br08003 Category | # of metabolite |
---|---|
Pyridine alkaloids | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Pyridine alkaloids | C00153 | C00000209 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00000209
![]() |
Vitamin B
/ Nicotinamide |
CHEMBL1140
|
D009536
|
96 / 36 / 31 | 24 / 28 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000209 | 1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000209 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000209 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000209 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00000209 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000209 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000209 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000209 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000209 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000209 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000209 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000209 | 2 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000209 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000209 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000209 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000209 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000209 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000209 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000209 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000209 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000209 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000209 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000209 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000209 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000209 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000209 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000209 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000209 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000209 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000209 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000209 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000209 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000209 | 1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000209 | 0 / 0 |
Q8IXJ6 | NAD-dependent protein deacetylase sirtuin-2 | Enzyme | C00000209 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000209 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000209 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000209 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000209 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000209 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000209 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000209 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000209 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000209 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000209 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000209 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000209 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000209 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000209 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000209 | 1 / 0 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00000209 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000209 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000209 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000209 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000209 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000209 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000209 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000209 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000209 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000209 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000209 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000209 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000209 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000209 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000209 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000209 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000209 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000209 | 0 / 0 |
Q9NTG7 | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Enzyme | C00000209 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000209 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000209 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000209 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000209 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000209 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000209 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000209 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000209 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000209 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000209 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000209 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000209 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000209 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000209 | 0 / 0 |
Q96EB6 | NAD-dependent protein deacetylase sirtuin-1 | Enzyme | C00000209 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000209 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000209 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000209 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000209 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000209 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000209 | 0 / 0 |
Q9NXA8 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | Enzyme | C00000209 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
31 | ACACA, ACAC, ACACAD, ACC, ACC1, ACCA | acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
C00000209
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000209
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000209
|
6364 | CCL20, CKb4, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 | chemokine (C-C motif) ligand 20 |
C00000209
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000209
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00000209
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00000209
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000209
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000209
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000209
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00000209
|
389692 | MAFA, RIPE3b1, hMafA | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
C00000209
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000209
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00000209
|
4967 | OGDH, AKGDH, E1k, OGDC | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) (EC:1.2.4.2) |
C00000209
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00000209
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00000209
|
5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00000209
|
6194 | RPS6, S6 | ribosomal protein S6 |
C00000209
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00000209
|
22933 | SIRT2, SIR2, SIR2L, SIR2L2 | sirtuin 2 (EC:3.5.1.-) |
C00000209
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000209
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000209
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000209
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D007516 | Adenoma, Islet Cell |
C00000209
|
D020520 | Brain Infarction |
C00000209
|
D002545 | Brain Ischemia |
C00000209
|
D002653 | Child Behavior Disorders |
C00000209
|
D002972 | Cleft Palate |
C00000209
|
D003921 | Diabetes Mellitus, Experimental |
C00000209
|
D003924 | Diabetes Mellitus, Type 2 |
C00000209
|
D056486 | Drug-Induced Liver Injury |
C00000209
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000209
|
D006330 | Heart Defects, Congenital |
C00000209
|
D006937 | Hypercholesterolemia |
C00000209
|
D006943 | Hyperglycemia |
C00000209
|
D006948 | Hyperkinesis |
C00000209
|
D006951 | Hyperlipoproteinemias |
C00000209
|
D006973 | Hypertension |
C00000209
|
D015228 | Hypertriglyceridemia |
C00000209
|
D052456 | Hypoalphalipoproteinemias |
C00000209
|
D007674 | Kidney Diseases |
C00000209
|
D007680 | Kidney Neoplasms |
C00000209
|
D017880 | Limb Deformities, Congenital |
C00000209
|
D009410 | Nerve Degeneration |
C00000209
|
D019636 | Neurodegenerative Diseases |
C00000209
|
D010190 | Pancreatic Neoplasms |
C00000209
|
D010391 | Pemphigoid, Bullous |
C00000209
|
D012393 | Rosacea |
C00000209
|
D012640 | Seizures |
C00000209
|
D020521 | Stroke |
C00000209
|
D014657 | Vasculitis |
C00000209
|